Infectious Disease Diagnostics - Global Market Outlook (2018-2027)

According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $15.53 billion in 2018 and is expected to reach $28.79 billion by 2027 growing at a CAGR of 7.1% during the forecast period. Increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of infectious diseases are the major factors propelling the market growth. However, lack of skilled technicians/professionals and high cost of these devices is hampering the market growth.

Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Any bacteria which cause infectious disease are called pathogens. Diagnosis for the causative organism of bacterial disease is always difficult since infections show symptoms like lethargy and fever.

Based on the technology, DNA sequencing & next-generation sequencing (NGS) segment is going to have a lucrative growth during the forecast period due to factors such as development in sequencing technologies, rising awareness and taking of personalized medicine in which this technology has major applications and growing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing are expected to boost the growth of this technology in the future. By geography, North America is likely to have a huge demand owing to extremely developed healthcare system, mounting prevalence of infectious diseases, the existence of a huge number of leading national clinical laboratories, and simple accessibility to technologically advanced devices in the region.

Some of the key players profiled in the Infectious Disease Diagnostics Market are Abbott Diagnostic, Alere, Beckman Coulter , Becton, Dickinson and Company (BD), bioMérieux, Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diasorin, Diaxonhit , Eiken Chemical, EMD Millipore, J.Mitra, Meridian Bioscience, Roche Diagnostic , Siemens Healthcare Diagnostics, TECHLAB, Thermo Fisher Scientific  and Trinity Biotech.

Product & Services Covered:
• Assays, Kits, & Reagents
• Instruments
• Software

Test Types Covered:
• Biopsies
• Imaging Test
• Laboratory Tests

Technologies Covered:
• Biochemical Characterization
• Clinical Microbiology
• Conventional Techniques
• DNA Microarray
• DNA Sequencing & Next-Generation Sequencing (NGS)
• Hybridization and Microarrays
• Immunodiagnostics
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Microscopy 
• Molecular Techniques
• POC infectious disease diagnostics test
• Polymerase Chain Reaction (PCR)

Disease Types Covered:
• Acquired Immunodeficiency Syndrome (AIDS)
• Bacterial Infection
• Cardiovascular infection
• Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
• Coronavirus
• Glandular fever
• Hepatitis
• Hospital-Acquired Infections (HAIS)
• Human Immunodeficiency Virus (HIV)
• Human Papillomavirus (HPV)
• Influenza
• Methicillin-resistant Staphylococcus Aureus (MRSA)
• Tuberculosis (TB)
• Other Disease Types

End Users Covered:
• Academic/Research Institutes
• Ambulatory Surgical Centers
• Blood Banks
• Contract Research Organization
• Diagnostic Clinics
• Home healthcare
• Hospital/Clinical Laboratories
• Nursing Homes
• Physician Offices
• Reference Laboratories

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances